Disrupting Alzheimer’s Disease Research

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that devastates the brain—affecting cognitive function, memory, visual spatial perception, abstract thinking, and eventually loss of bodily functions. Based on the latest Rand report on dementia and AD, the current costs in lives lost, families shattered, careers disrupted, and financial futures ruined is much too high. And with the projected increases in the number of individuals affected by AD and related dementias in coming years, the global costs become unendurable and insupportable.

Read the full article.


Global Forum

Meryl Comer speaks at the 2013 Global Forum: “Our mission is early AD diagnosis, which further defines our role as a catalyst funder for open source ‘Global NeuroDiscovery’ challenges that aim to advance innovation in self- administered mobile applications for brain health, Alzheimer’s clinical trial data mining for sex- based differences, and validation studies of mobile digital devices for assessing and tracking early cognitive decline.”

Read Meryl’s full remarks.


Geoffrey Beene Foundation Alzheimer’s Initiative Announces $100,000 Innovation Challenge

Washington, DC (April 30, 2013) — The Geoffrey Beene Foundation Alzheimer’s Initiative last night launched the 2013 Geoffrey Beene Global NeuroDiscovery Challenge at the April 29 Society for Women’s Health Research Gala at the Mandarin Hotel in Washington, DC. It is the Foundation’s second online innovation challenge, but the first to ask solvers to identify male/female differences in early cognitive decline, to promote earlier interventions for both women and men. Winning submissions will share $100,000 in prize awards.